This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
National Institute for Health and Clinical Excellence.NICE recommends a scheme to make bortezomib (Velcade) for multiple myeloma accessible to NHS patients. Media Release: 4 Jun 2007. Available from: URL: http://www.nice.org.uk
About this article
Cite this article
UK NICE has recommended a scheme which would make bortezomib more accessible to UK NHS patients with multiple myeloma. Pharmacoecon. Outcomes News 530, 3 (2007). https://doi.org/10.2165/00151234-200705300-00008
- Public Health
- Health Outcome
- Multiple Myeloma
- Partial Response